| 查看: 436 | 回复: 0 | |||
[交流]
The basis of submission中的basis该怎样理解？
|
|
1.Basis of Submission for an ANDA for a Generic Drug that is the Same as its RLD When an applicant submits an ANDA for a generic drug that is the same as its RLD, the basis of submission is the RLD. Accordingly, the name of the RLD, including dosage form and strength, and its application number should be provided as the basis of submission on Form FDA 356h (i.e., the form that accompanies regulatory submissions by an applicant) and in the appropriate sections of the ANDA. 发自小木虫Android客户端 |
回复此楼» 猜你喜欢
家人们做LDH为啥会出现负值啊
已经有0人回复
-
有偿求肠毒素的脆弱拟杆菌（ETBF）
已经有0人回复
-
药物学论文润色/翻译怎么收费?
已经有125人回复
-
博导推荐
已经有2人回复
-
哪里做甘氨酸受体与配体结合率的试验
已经有0人回复
-
关于SCI杂志发表挂名
已经有32人回复
